Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Alida Biosciences Inc
Profile last edited on: 8/31/2022      CAGE: 8TRS7      UEI: G7KLMNRJCFH3

Business Identifier: Next generation RNA analysis tools: enabling new medical treatments and diagnostic assays.
Year Founded
2020
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

11425 Sorrento Valley Road
San Diego, CA 92129
   (720) 375-1071
   info@alidabio.com
   www.alidabio.com
Location: Single
Congr. District: 50
County: San Diego

Public Profile

SBIR involved in the very early stages of their formation and describing what they do as Unlocking RNA Biology, specializing in NGS, Omics, RNA Biology, and RNA drugs, Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays to improve human health.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$774,118
Phase II Dollars
$0
Total Awarded
$774,118

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2024 2 NIH $1,985,413
Project Title: Multiplexed Analysis of the Epitranscriptome
2023 2 NIH $1,366,974
Project Title: Rapid NGS Method for Mapping of the Epitranscriptome
2022 1 NIH $259,554
Project Title: Positional Marking of RNA Modifications
0 1 NIH $347,653
Project Title: Engineered RNA Modification Recognition

Key People / Management

  Gudrun Stengel -- CEO & Co-Founder

  Zachary Miles

Company News

There are no news available.